8 February 2022 in British Journal Of Neurosurgery
AO Spine RECODE-DCM (Research objectives and common data elements for degenerative cervical myelopathy) has highlighted that the subjective disability reported by people living with DCM is much bro...
1 January 2021 in Nutrition and Metabolic Insights
Introduction: Degenerative cervical myelopathy (DCM) is the commonest cause of adult spinal cord impairment worldwide, encompassing chronic compression of the spinal cord, neurological disability and diminished quality of life. Evidence on the contribution of environmental factors is sparse; in particular, the role of nutrition in DCM is unknown. The objective of this review was to assess the effect of nutrition on DCM susceptibility, severity and surgical outcome. Methods: A systematic review in MEDLINE and Embase was conducted following PRISMA guidelines. Full-text papers in English papers, focussing on cervical myelopathy and nutrition, published before January 2020 were considered eligible. Quality assessments were performed using the GRADE assessment tool. Patient demographics, nutritional factor and DCM outcomes measures were recorded. Relationships between nutritional factors, interventions and disease prognosis were assessed. Results: In total, 5835 papers were identified of which 44 were included in the final analysis. DCM patients with pathological weight pre-operatively were more likely to see poorer improvements post-surgically. These patients experienced poorer physical and mental health improvements from surgery compared to normal weight patients and were more likely to suffer from post-operative complications such as infection, DVT, PE and hospital readmissions. Two trials reporting benefits of nutritional supplements were identified, with 1 suggesting Cerebrolysin to be significant in functional improvement. An unbalanced diet, history of alcohol abuse and malnourishment were associated with poorer post-operative outcome. Conclusion: Although the overall strength of recommendation is low, current evidence suggests nutrition may have a significant role in optimising surgical outcome in DCM patients. Although it may have a role in onset and severity of DCM, this is a preliminary suggestion. Further work needs to be done on how nutrition is defined and measured, however, the beneficial results from studies with nutritional interventions suggest nutrition could be a treatment target in DCM.
16 April 2026 in Head & Neck
1 March 2026 in JRSM Open
Summary: Objective: Hormone replacement therapy (HRT) is used to manage menopausal symptoms, but its perioperative use raises concerns about increased venous thromboembolism (VTE) risk. Clinical guidelines vary, with some advising temporary discontinuation before surgery. This scoping review aims to synthesise evidence and guidance on whether perioperative cessation of HRT influences postoperative VTE risk. Design: A systematic search of PubMed and the Cochrane Library identified studies evaluating pre-operative HRT and VTE outcomes. Search terms included Hormone Replacement Therapy, HRT, Venous Thromboembolism, Venous Thrombosis, Pulmonary Embolism, Perioperative Care and Surgical Procedures, Operative. Participants: Studies included adult women on HRT undergoing surgery and assessed discontinuation and VTE risk. Data were synthesised narratively. Results: The search identified 246 records, four of which met the inclusion criteria: three primary studies and one systematic review. Only one study compared perioperative continuation versus cessation of HRT and found no significant increase in postoperative VTE with continued use. Other studies examined HRT among multiple VTE risk factors, with inconsistent findings. Clinical guidelines recognise oral oestrogen as a VTE risk factor and distinguish between higher-risk oral and lower-risk transdermal formulations; however, few provide explicit perioperative recommendations. Conclusion: Evidence is limited and insufficient to support routine perioperative HRT cessation. The only comparative study found no significant increase in VTE with continuation, though limitations restrict interpretation. Overall, the literature reflects uncertainty. Given limited and heterogeneous data, perioperative HRT management should be individualised. Further prospective research is needed to determine whether temporary withdrawal, particularly of oral oestrogen, reduces postoperative VTE risk.